mRNA |
paclitaxel |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
4e-06 |
mRNA |
tubastatin A |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
4e-06 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
9e-06 |
mRNA |
RG-108 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-05 |
mRNA |
HLI 373 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
1e-05 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
2e-05 |
mRNA |
BRD-K28456706 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-05 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-05 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
2e-05 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
2e-05 |